The relevant section of the transcript is to the right; you can click to enlarge it. I'm going to share the disturbing sections here. Discussing Digoxin, a drug often used to kill fetuses prior to starting the actual procedure, the StemExpress representative said, "A lot of women have had other problems due to [Digoxin]. Oregon State put out a paper saying women are more likely to have issues getting pregnant later."
StemExpress: We've provided some of those papers to physicians in clinics in the past. It's interesting, I think, because the doctors that love [Digoxin] don't want to look at those papers.
Buyer: Wait a minute, let me understand this. Digoxin can present problems for women to get pregnant later, but the doctors know that, but love using it and don't want to look at that.
StemExpress: Well they argue, what they're going to argue is, they're going to say, "I don't want to look at the paper."I can't determine from the discussion in the transcript exactly what the concern is. There's some mention of hemorrhage risks. The StemExpress representative goes on to say:
I don't remember the physician that worked on it, but he was great. She basically did some examples where they were injecting Dig into the fetus, days before she did similar examples where they were injecting uh, air. Just did an air injection, it was the same result. It's cheaper. Dig is more expensive, it's mroe toxic to the woman. He was like, "You could use air, you could use alcohol." She was using like one hundred cc's of like, ethanol. Done. Stopped the fetal heart.
The StemExpress representative blames the adherence to Digoxin rather than air or ethanol as relating to "big pharma" wanting to get more money. There might be issues of the relative toxicity of a feticidal dose of ethanol versus Digoxin versus air should the injection accidentally get into the mother's blood stream.
I can't find the study in question, but I'll keep looking. Stay tuned for possible updates.